ArticleThrombosis research2021
Three-month follow-up of pulmonary embolism in patients with COVID-19.
Article in Thrombosis research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Chronic Dyspnea and Residual Pulmonary Vascular Sequelae After COVID-19 Pulmonary Embolism: A Retrospective Analysis.Pulmonary circulation · 2025Article
- COVID-19 and Recurrent Venous Thromboembolism (CORE-VTE).The Canadian journal of hospital pharmacy · 2025Article
- Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.International journal of molecular sciences · 2024Article
- The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19.Journal of cardiovascular development and disease · 2023Review
- Risk of thrombosis recurrence among patients with COVID-19 and surgery-associated venous thromboembolism.Revista clinica espanola · 2023Observational
- [Risk of thrombosis recurrence among patients with COVID-19- and surgery-associated venous thromboembolism].Revista clinica espanola · 2023Article
- Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.The European respiratory journal · 2023Article
- Lung perfusion assessed by SPECT/CT after a minimum of three months anticoagulation therapy in patients with SARS-CoV-2-associated acute pulmonary embolism: a retrospective observational study.Respiratory research · 2022Observational
- Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.Journal of thrombosis and thrombolysis · 2022Article
- Pulmonary thromboembolic events in COVID-19-A systematic literature review.Pulmonary circulation · 2022Review
- Article
- Diagnostic Management of Acute Pulmonary Embolism in COVID-19 and Other Special Patient Populations.Diagnostics (Basel, Switzerland) · 2022Review
- Long-COVID diagnosis: From diagnostic to advanced AI-driven models.European journal of radiology · 2022Review
- Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?Cardiology and therapy · 2021Review
- Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge.Research and practice in thrombosis and haemostasis · 2021Article
- Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases.Experimental hematology & oncology · 2021Article
Corrections and comments
- Comment on
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.